Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Return on Equity (2023 - 2025)

Mangoceuticals' Return on Equity history spans 3 years, with the latest figure at 0.01% for Q4 2025.

  • On a quarterly basis, Return on Equity fell 1.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 1.0% decrease, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q4 2025 for Mangoceuticals, down from 0.01% in the prior quarter.
  • Over the last five years, Return on Equity for MGRX hit a ceiling of 0.98% in Q1 2024 and a floor of 0.09% in Q4 2023.
  • Historically, Return on Equity has averaged 0.08% across 3 years, with a median of 0.01% in 2025.
  • Biggest five-year swings in Return on Equity: grew 8bps in 2024 and later plummeted -99bps in 2025.
  • Tracing MGRX's Return on Equity over 3 years: stood at 0.09% in 2023, then surged by 93bps to 0.01% in 2024, then crashed by -113bps to 0.01% in 2025.
  • Business Quant data shows Return on Equity for MGRX at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.